Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-12-01
著者
-
手良向 聡
癌病態治療研究会メタアナリシス研究班
-
手良向 聡
京都大学附属病院探索医療センター検証部
-
TERAMUKAI Satoshi
Translational Research Informatics Center
-
Fukushima Masanori
Translational Research Informatics Center
-
Teramukai Satoshi
Department Of Clinical Trial Design And Management Translational Research Center Kyoto University Ho
-
Nishimura Tsutomu
Outpatient Oncology Unit Kyoto University Hospital Faculty Of Medicine Kyoto University
-
Teramukai Satoshi
Department Of Preventive Medicine Faculty Of Medical Sciences Kyushu University
-
Teramukai Satoshi
Department Of Health Science University Of Tokyo
-
Ohuchi Noriaki
Department Of Breast Surgery Tohoku University
-
Fukushima Masanori
Department Of Experimental Therapeutics Translational Research Center Kyoto University Hospital Facu
-
Fukushima Masanori
Translational Research Center Graduate School Of Medicine Kyoto University
-
Nishimura Tsutomu
Translational Research Center Graduate School Of Medicine Kyoto University
-
手良 向聡
京都大学医学部附属病院探索医療部検証部
-
Ishida Takanori
Department Of Radiological Technology School Of Health Sciences Faculty Of Medicine
-
手良 向聡
京都大学医学部附属病院探索医療センター検証部
-
Ishida Takanori
Department Of Surgical Oncology Tohoku University School Of Medicine
-
MATSUBARA Yoshihiro
Translational Research Informatics Center
-
SAKABAYASHI Satomi
Translational Research Informatics Center
-
Ohuchi Noriaki
Department Of Surgical Oncology Tohoku University School Of Medicine
-
手良向 聡
Department of Clinical Trial Design and Management, Translational Research Center, Kyoto University Hospital, Faculty of Medicine, Kyoto University
関連論文
- がん化学療法による悪心・嘔吐発現の性差
- 電子カルテ二次利用臨床研究用データ収集システムの開発と展望
- P-156 局所進行型肺非小細胞癌に対する化学放射線併用療法の多施設間治療成績(脳転移・集学的治療, 第47回日本肺癌学会総会)
- WS2b-8 Evidence based medicineの観点からみた, 癌の補助化学, 免疫療法の評価
- P-151 進行非小細胞肺癌に対する臨床第3相比較試験(JMTOLC00-03)登録患者のQOL評価研究(一般演題(ポスター) 肺癌治療とQOL療,第48回日本肺癌学会総会)
- P11-6 ゲフィチニブ(イレッサ_[R!○])による有害事象の発現および効果に関するレトロスペクティブ調査(JMTO LC03-02)(ポスター総括11 : 基礎 ゲフィチニブ(臨床))
- 血管再生医療における臨床試験デザインについて
- 医師主導臨床研究における薬剤管理業務の現状と課題
- 医師主導がん臨床試験における症例報告書の作成支援
- HP-079-1 観察研究実施計画書(プロトコル)に関する作成要領の策定と公開(臨床試験等,ハイブリッドポスター,第109回日本外科学会定期学術集会)
- W3-1 各種 BRMを用いた消化器癌に対する補助免疫化学療法のメタアナリシスによる再評価(第52回日本消化器外科学会総会)
- トランスレーショナルリサーチから医師主導臨床試験のための基盤整備
- 胃癌における術前 immunosuppressive acidic Protein 値と予後との関連
- 横紋筋肉腫全国調査の結果と問題点
- 局所進行型肺非小細胞癌に対する化学放射線併用療法の多施設間治療成績の比較調査(15 集学的治療, 小細胞の治療, 第46回 日本肺癌学会総会)
- P9-70 全国規模の肺癌外科手術例のアウトカム評価 : 94年と98年の病理病期別5年生存率について(ポスター総括9 : 外科3 合併切除・縦隔鏡・その他)
- P-740 京都大学病院における医師主導治験の審査体制(16.臨床試験(治験)2,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)
- PD-2-04 進行胃癌77例の術前化学療法の解析とTS-1/CDDP術前化学療法の臨床研究 : Phase II/III(パネルディスカッション2 : 進行・再発胃癌に対する新たな治療戦略)
- 1423 PSKによる胃癌に対する補助免疫化学療法のメタアナリシスによる再評価(胃化学療法7,一般演題,第61回日本消化器外科学会定期学術総会)
- DP-022-4 腹腔鏡下Rb直腸癌手術に対する術前放射線化学療法の効果(第108回日本外科学会定期学術集会)
- P-2-498 腹腔鏡下結腸cSM癌手術もD2以上の郭清が必要(大腸・肛門 危険因子・予後2,一般演題(ポスター),第62回日本消化器外科学会定期学術総会)
- Coronary Risk Factor Profile and Prognostic Factors for Young Japanese Patients Undergoing Coronary Revascularization
- B-5 Gaussian Frailty Modelsにおける推定バイアスの検討(Cox比例ハザードモデルとその周辺)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
- Gaussian Frailty Model における推定バイアスの検討
- Age-specific interval breast cancers in Japan : estimation of the proper sensitivity of screening using a population-based cancer registry
- Cost-effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years
- Breast Conserving Surgery with Primary Volume Replacement using a Lateral Tissue Flap
- Collaboration of Breast Cancer Clinic and Genetic Counseling Division for BRCA1 and BRCA2 Mutation Family in Japan
- A Case Control Study on the Effectiveness of Breast Cancer Screening by Clinical Breast Examination in Japan
- 第3部 パネルディスカッション(日本の小児がん(特に複数科集学的治療を要する固形腫瘍)グループスタディ事務局の過去の実績と未来への提言,小児がん京都会議2003)
- PJ-740 Comparison of Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Graft Surgery (CABG) in Diabetic Patients (pts) : For the CREDO Investigators(Coronary revascularization, PCI-20, The 71st Annual Scientific Meeting of the Japanese C
- 2 Prognosis of Japanese Patients after Coronary Revascularization : Perspectives from CREDO-Kyoto Registry(Therapeutic Decision Making for Coronary Artery Disease Among PCI, CABG, and Medication,Symposium 3 (SY-03) (IHD),The 73rd Annual Scientific Meeting
- 臨床試験の支援のしくみとあり方 (特集 癌臨床試験を支援する機構のあり方--第44回日本癌治療学会総会シンポジウムより)
- APP-041 浸潤性膀胱癌症例におけるリンパ節郭清の臨床的意義に関する多施設共同研究(総会賞応募(ポスター))
- トランスレーショナルリサーチから臨床試験へ
- 3 Prevalence and Significance of Risk Factors in Japanese Patients Undergoing Coronary Revascularization : from CREDO-Kyoto Registry(Comprehensive Risk Management for Prevention of Coronary Artery Disease,Symposium 16 (SY-16) (H),The 73rd Annual Scientifi
- Risk of Breast Cancer in Japanese Women with Benign Breast Disease
- Risk Factors for Benign Breast Disease according to Histopathological Type : Comparisons with Risk Factors for Breast Cancer
- Quality assurance in mammography - screen-film characteristic and nationwide survey of raidation dose and image quality -.
- UGT1A1^*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
- Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy
- Association of Clinical Characteristics with Disease Subtypes, Initial Visual Acuity, and Visual Prognosis in Neovascular Age-Related Macular Degeneration
- FRS-085 Sodium Intake in Men and Potassium Intake in Women Related to Metabolic Syndrome in Japanese Hypertensive Patients : OMEGA Study(FRS18,New Insights into Metabolic Syndrome (H),Featured Research Session (English),The 73rd Annual Scientific Meeting
- OMEGA Study : Design, Baseline Data, Metabolic Syndrome Prevalence in a Large-Scale Observational Study of Hypertensive Patients : The Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement
- Phase I/II Clinical Trial : Transplantation of Autologous Endothelial Progenitor Cells in Patients with Chronic Critical Limb Ischemia(Angiogenesis 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Impact of Splenectomy and Immunochemotherapy on Survival Following Gastrectomy for Carcinoma: Covariate Interaction with Immunosuppressive Acidic Protein, A Serum Marker for the Host Immune System
- Better Survival With Statin Administration After Revascularization Therapy in Japanese Patients With Coronary Artery Disease : Perspectives From the CREDO-Kyoto Registry
- OE-007 Impact of Statins on the Outcome of Patients after Coronary Revascularization in the Real World Clinical Practice : CREDO-Kyoto Study(Coronary revascularization, PCI(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japa
- PS-126-2 肝細胞癌切除後予後予測におけるFDG-PETの意義
- A Case fo Breast Cancer Metastatic to the Pituitary Gland
- PJ-735 Comparison of PCI and CABG among Patients with a Chronic Total Occlusion and Multi-vessel Disease : From the CREDO-Kyoto(Coronary revascularization, PCI-19, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-116 Comparison of PCI and CABG in Patients With Multi-Vessel Disease and Reduced Left Ventricular Function : From the CREDO-Kyoto(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Long-term Outcome of Breast-conserving Therapy for Breast Cancer
- PJ-587 Impact of Complete Revascularization on Long-term Outcome for Diabetes Patients after Percutaneous Coronary Intervention in BMS Era : From CREDO-Kyoto Registry(Coronary revascularization, PCI-13, The 71st Annual Scientific Meeting of the Japanese C
- PJ-264 Comparison of PCI and CABG in Patients with Multi-Vessel Disease and a Prior History of Cerebrovascular Accident : From CREDO-Kyoto Study(Myocardial ischemia/reperfusion, basic/clinical-5, The 71st Annual Scientific Meeting of the Japanese Circulat
- PJ-186 Impact of Renal Insufficiency Degrees on the Long-term Outcome of Initial Coronary Revascularization for Multi-vessel Diseases from CREDO-Kyoto(Angina pectoris, basic/clinical-4, The 71st Annual Scientific Meeting of the Japanese Circulation Societ
- PJ-185 Impact of Mode of Initial Coronary Revascularization for Multivessel Diseases in Several Renal Insufficiency Degrees from CREDO-Kyoto(Angina pectoris, basic/clinical-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-470 Anemia Predicts 3-Years Mortality and Cardiovascular Events in Patients Undergoing Elective Revascularization : from the CREDO-Kyoto(Chronic coronary heart disease/Remodeling-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society
- Retinoic Acid Receptor and Retinoid X Receptor in Ductal Carcinoma in situ and Intraductal Proliferative Lesions of the Human Breast
- FRS-086 Comparison of Survival After Coronary Revascularization of Diabetic Patients Receiving Insulin Versus Those Receiving only Diet and/or Oral Hypoglycemic Agents.(New Insights into Metabolic Syndrome(01)(H),Featured Research Session,The 72nd Annual
- PE-486 Three-Year Outcome in Patients with Chronic Total Occlusions Undergone Successful Percutaneous Coronary Intervension(Coronary revascularization, PCI-10, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-387 Impact of Pharmacotherapy at Discharge for Complicated Risk Factors on Outcomes of Diabetic Patients Undergoing First Coronary Revascularization(Cardiovascular pharmacology, basic/clinical-4, The 71st Annual Scientific Meeting of the Japanese Circu
- FRS-009 Long-term Outcome after Percutaneous Coronary Intervention as Compared with Coronary Artery Bypass Grafting in BARI-like Patients : From the CREDO-Kyoto Registry(Coronary Revascularization (clinical) 1, The 71st Annual Scientific Meeting of the Ja
- PJ-353 Comparison of Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Graft Surgery (CABG) in Patients with Multi-vessel Disease (MVD)(Coronary revascularization, PCI-15 (IHD) PJ60,Poster Session (Japanese),The 70th Anniversary Annual S
- 4 Concurrent Vasculogenesis and Cardiomyogenesis by Somatic Stem/Progenitor Cell Transplantation for Functional Regenerative Recovery Post Myocardial Infarction(Cell Death and Repair-Regeneration in Cardiac and Vascular Diseases,Plenary Session 3 (PL3) (M
- Androgens in human breast carcinoma
- Molecular morphological approach to the pathological study of development and advancement of human breast cancer
- Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast
- Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma : Possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression
- Vasohibin-1 in human breast carcinoma : A potential negative feedback regulator of angiogenesis
- Intratumoral estrogen production in breast carcinoma : significance of aromatase
- Aromatase in Human Breast Carcinoma as a Key Regulator of Intratumoral Sex Steroid Concentrations
- Prediction of breast cancer prognosis by gene expression profile of TP53 status
- Significance of irradiation in breast-conserving treatment : comparison of local recurrence rates in irradiated and nonirradiated groups
- Significance of Pathological Evaluation for Lymphatic Vessel Invasion in Invasive Breast Cancer
- Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma
- In situ production of sex steroids in human breast carcinoma
- Pathological Aspects of Core Needle Biopsy for Non-Palpable Breast Lesions
- Ductal Carcinoma in situ and Related Lesions of the Breast : Recent Advances in Pathology Practice
- Invasive micropapillary carcinoma of the breast : Clinicopathological and immunohistochemical study
- Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases
- In situ Production of Estrogens in Human Breast Carcinoma
- Immunohistochemical expression of gonadotropin releasing hormone receptor in human breast carcinoma
- Comparison of False Negative Rates among Breast Cancer Screening Modalities with or without Mammography: Miyagi Trial
- In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine
- Characterization and In Vitro Cytotoxic Effect of Adriamycin-conjugated Monoclonal Antibody Prepared Against Breast Cancer Cell Line
- OE-326 Transplantation of Endothelial Progenitor Cells is Safe and Effective for Therapeutic Neovascularization in No-Option Patients with Chronic Critical Limb Ischemia(Regeneration (angionenesis/myocardial regeneration)-2 (M) OE55,Oral Presentation (Eng
- W1-9 胃癌治癒切除と免疫パラメーターの変動(第37回日本消化器外科学会総会)
- 二値エンドポイントの単群臨床試験におけるベイズ流デザイン
- A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan
- Insulin-like Growth Factor (IGF)-I, IGF-binding Protein-3 and Colorectal Adenomas in Japanese Men
- 代替エンドポイントの評価のための統計的基準とその適用事例
- Plasma ghrelin levels in healthy elderly volunteers: the levels of acylated ghrelin in elderly females correlate positively with serum IGF-I levels and bowel movement frequency and negatively with systolic blood pressure (平成20年度助成研究論文) -- (優秀論文助成 受賞者)
- Outcome of different post-orchiectomy management for stage I seminoma : Japanese multi-institutional study including 425 patients
- Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients : OMEGA Study
- Surrogacy of tumor response and progression-free survival for overall survival in metastatic breast cancer resistant to both anthracyclines and taxanes
- Phase II Clinical Trial of CD34+ Cell Therapy to Explore Endpoint Selection and Timing in Patients With Critical Limb Ischemia
- PD-2-3 進行胃癌に対する術前化学療法(PD パネルディスカッション,第113回日本外科学会定期学術集会)
- Clinical effects of ghrelin on gastrointestinal involvement in patients with systemic sclerosis
- Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer